β-Endorphin, equine TFA is an endogenous opioid peptide, which binds at high affinity to both μ/δ opioid receptors . β-Endorphin, equine TFA has analgesic properties . Appearance:Solid IC50& Target:δ Opioid Receptor/DOR μ Opioid Receptor/MOR In Vitro:β-Endorphin, equine TFA (0, 0.6, 1.2 and 3 μM) inhibits the striatal dopamine release. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo:β-Endorphin, equine TFA (2 or 20 μg/kg; i.p., once) effects the acquisition and retention in the rat. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Adult Female Wistar ratsDosage: 2 Biological Activity:β-Endorphin, equine TFA is an endogenous opioid peptide, which binds at high affinity to both μ/δ opioid receptors . β-Endorphin, equine TFA has analgesic properties .
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
β-Endorphin, equine TFA
CAS number：unknown molecular formula：C156H249F3N42O46S
overview
compound introduction
Specs
| Chinese alias | β-内啡肽，马 TFA | ||
| English alias | - | ||
| CAS number | unknown | molecular formula | C156H249F3N42O46S |
| molecular weight | 3537.96 g/mol | Exact mass | - |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
